1. Home
  2. RGEN vs ATI Comparison

RGEN vs ATI Comparison

Compare RGEN & ATI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • ATI
  • Stock Information
  • Founded
  • RGEN 1981
  • ATI 1960
  • Country
  • RGEN United States
  • ATI United States
  • Employees
  • RGEN N/A
  • ATI N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • ATI Steel/Iron Ore
  • Sector
  • RGEN Health Care
  • ATI Industrials
  • Exchange
  • RGEN Nasdaq
  • ATI Nasdaq
  • Market Cap
  • RGEN 8.2B
  • ATI 8.4B
  • IPO Year
  • RGEN N/A
  • ATI N/A
  • Fundamental
  • Price
  • RGEN $141.78
  • ATI $61.83
  • Analyst Decision
  • RGEN Buy
  • ATI Strong Buy
  • Analyst Count
  • RGEN 10
  • ATI 8
  • Target Price
  • RGEN $188.38
  • ATI $74.00
  • AVG Volume (30 Days)
  • RGEN 926.2K
  • ATI 1.4M
  • Earning Date
  • RGEN 10-29-2024
  • ATI 10-31-2024
  • Dividend Yield
  • RGEN N/A
  • ATI N/A
  • EPS Growth
  • RGEN N/A
  • ATI N/A
  • EPS
  • RGEN N/A
  • ATI 2.65
  • Revenue
  • RGEN $602,354,000.00
  • ATI $4,227,800,000.00
  • Revenue This Year
  • RGEN $0.08
  • ATI $8.08
  • Revenue Next Year
  • RGEN $12.97
  • ATI $8.96
  • P/E Ratio
  • RGEN N/A
  • ATI $23.45
  • Revenue Growth
  • RGEN N/A
  • ATI 2.45
  • 52 Week Low
  • RGEN $110.45
  • ATI $35.03
  • 52 Week High
  • RGEN $211.13
  • ATI $68.92
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 43.50
  • ATI 49.44
  • Support Level
  • RGEN $138.80
  • ATI $57.30
  • Resistance Level
  • RGEN $150.72
  • ATI $63.37
  • Average True Range (ATR)
  • RGEN 4.98
  • ATI 1.96
  • MACD
  • RGEN -0.92
  • ATI -0.24
  • Stochastic Oscillator
  • RGEN 24.50
  • ATI 44.73

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

About ATI ATI Inc.

ATI Inc supplies specialty metals to various end markets, including aerospace and defense, oil and gas, automotive, and electrical energy, among many others. The company's operating segment includes High-Performance Materials and Components and Advanced Alloys and Solutions. The majority of revenue is from the High-Performance Materials segment. The High-Performance Materials segment is focused on a wide range of high-performance specialty materials, parts, and components for several major end markets, including the aerospace & defense, medical, and energy markets. Geographically, it operates in the United States, China, the United Kingdom, Germany, France, Canada, and Others, the majority is from the United States.

Share on Social Networks: